Autonomix Medical, Inc. (AMIX) Price & Analysis

Compare

128 Followers

AMIX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.96 - $21.49

Previous CloseN/A

Volume72.00K

Average Volume (3M)1.07M

Market Cap

$6.86M

Enterprise Value$9.57M

Total Cash (Recent Filing)$8.59M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta-0.07

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-12.53

Shares Outstanding5,915,306

10 Day Avg. Volume278,586

30 Day Avg. Volume1,065,267

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.39

Enterprise Value/Revenue111.24

Enterprise Value/Gross Profit239.17

Enterprise Value/Ebitda-0.81

Forecast

1Y Price Target

$5.00

Price Target Upside323.73% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Clinical TrialsPositive preliminary results from the first 15 patients of its proof-of-concept trial showed significant and sustained pain reduction.

Market OpportunityThe potential to expand the addressable market beyond pancreatic cancer pain to other visceral cancers and earlier-stage pancreatic cancers could significantly enhance market opportunities.

Technology InnovationThe catheter-based sensing technology utilizes a proprietary microchip that is small enough to reach any organ and is 3,000x more sensitive than alternative methods.

Bears Say

Financial StatusThe company has sufficient capital to operate through F1Q27 with no debt.

Market Expansion RisksAMIX is pre-revenue, but its novel technology and significant initial market opportunity in pancreatic cancer pain management justify the price target.

Revenue StatusDespite being pre-revenue, the novel technology and significant initial market opportunity in pancreatic cancer pain management justify the valuation.

Autonomix Medical, Inc. News

Autonomix files to sell 1.57M shares of common stock for holders

17:04 EDT Autonomix (AMIX) files to sell 1.57M shares of common stock for holders Published first on TheFly...

9d ago

AMIX

Autonomix granted new European patent for catheter-based technology

Autonomix (AMIX) Medical announced that European Patent Office, EPO, has granted Patent No. 3,697,298, titled, “Medical Device with...

10d ago

AMIX

Autonomix finalizes design review of intravascular nerve sensing catheter

Autonomix (AMIX) Medical announced it has advanced its proprietary sensing catheter through a final design review in preparation...

16d ago

AMIX

Autonomix Medical Raises Stock Sales Price

The latest announcement is out from Autonomix Medical, Inc. ( ($AMIX) ). Autonomix Medical, Inc. announced an increase...

2d ago

AMIX

Autonomix Medical Enters $15M Purchase Agreement

An update from Autonomix Medical, Inc. ( ($AMIX) ) is now available. On August 25, 2025, Autonomix Medical,...

4d ago

AMIX

Autonomix Medical, Inc.: Promising Developments and Strategic Advancements Support Buy Rating

Anthony Vendetti, an analyst from Maxim Group, reiterated the Buy rating on Autonomix Medical, Inc.. The associated price...

10d ago

AMIX

Autonomix Medical Announces Warrant Exercise Offer

An announcement from Autonomix Medical, Inc. ( ($AMIX) ) is now available. On July 21, 2025, Autonomix Medical,...

1M ago

AMIX

Autonomix announces exercise of warrants for $2.5M gross proceeds

Autonomix (AMIX) Medical entered into agreements with certain holders of its existing warrants for the immediate exercise of...

1M ago

AMIX

Autonomix granted new U.S. patent on smart torquer device

Autonomix (AMIX) Medical announced the United States Patent and Trademark Office, USPTO, has issued U.S. Patent No. 12,295,646,...

1M ago

AMIX

Autonomix releases next CEO Corner segment

Autonomix (AMIX) Medical announced the next CEO Corner segment has been published on the Company’s website. For the...

2M ago

AMIX

Autonomix announces first patient enrolled, treated in follow-on phase to POC 2

Autonomix (AMIX) Medical, announced the first patient has been enrolled and treated in the follow-on phase to its...

2M ago

AMIX

Autonomix granted U.S. patent for catheter-based platform technology

Autonomix (AMIX) Medical announced the United States Patent and Trademark Office, USPTO, has issued U.S. Patent No. 12,279,889...

2M ago

AMIX

Autonomix granted approval to expand PoC human clinical trial

Autonomix (AMIX) Medical has received Ethics Committee authorization from the Ministry of Health of the Republic of Uzbekistan...

3M ago

AMIX

Autonomix granted key U.S. patent for catheter-based platform technology

Autonomix (AMIX) Medical announced the United States Patent and Trademark Office, USPTO, has issued U.S. Patent No. 12,257,071...

4M ago

AMIX

AMIX FAQ

What was Autonomix Medical, Inc.’s price range in the past 12 months?

Autonomix Medical, Inc. lowest stock price was $0.96 and its highest was $21.49 in the past 12 months.

What is Autonomix Medical, Inc.’s market cap?

Autonomix Medical, Inc.’s market cap is $6.86M.

When is Autonomix Medical, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Autonomix Medical, Inc.’s earnings last quarter?

Currently, no data Available

Is Autonomix Medical, Inc. overvalued?

According to Wall Street analysts Autonomix Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Autonomix Medical, Inc. pay dividends?

Autonomix Medical, Inc. does not currently pay dividends.

What is Autonomix Medical, Inc.’s EPS estimate?

Autonomix Medical, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Autonomix Medical, Inc. have?

Autonomix Medical, Inc. has 5,915,306 shares outstanding.

What happened to Autonomix Medical, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Autonomix Medical, Inc.?

Currently, no hedge funds are holding shares in AMIX

Company Description

Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Autonomix Medical, Inc. (AMIX) Earnings & Revenues

Currently, no data available

Please return soon. This page is being updated.

Historic Earnings Reports

AMIX Stock 12 Month Forecast

Average Price Target

$5.00

▲(323.73% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","21":"$21","5.25":"$5.25","10.5":"$10.5","15.75":"$15.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,5.25,10.5,15.75,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.6676923076923076,1.9453846153846155,2.223076923076923,2.500769230769231,2.7784615384615385,3.0561538461538467,3.333846153846154,3.611538461538462,3.8892307692307693,4.166923076923077,4.444615384615385,4.722307692307693,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.6676923076923076,1.9453846153846155,2.223076923076923,2.500769230769231,2.7784615384615385,3.0561538461538467,3.333846153846154,3.611538461538462,3.8892307692307693,4.166923076923077,4.444615384615385,4.722307692307693,{"y":5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.6676923076923076,1.9453846153846155,2.223076923076923,2.500769230769231,2.7784615384615385,3.0561538461538467,3.333846153846154,3.611538461538462,3.8892307692307693,4.166923076923077,4.444615384615385,4.722307692307693,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.6,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.4,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":11.71,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":10.92,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4.48,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.76,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.76,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.91,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.29,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.42,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.39,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >